Clonal analysis of immunodominance and cross-reactivity of the CD4 T cell response to SARS-CoV-2.
Saved in:
| Title: | Clonal analysis of immunodominance and cross-reactivity of the CD4 T cell response to SARS-CoV-2. |
|---|---|
| Authors: | Low JS; Institute for Research in Biomedicine, Università della Svizzera italiana, 6500 Bellinzona, Switzerland., Vaqueirinho D; Institute for Research in Biomedicine, Università della Svizzera italiana, 6500 Bellinzona, Switzerland., Mele F; Institute for Research in Biomedicine, Università della Svizzera italiana, 6500 Bellinzona, Switzerland., Foglierini M; Institute for Research in Biomedicine, Università della Svizzera italiana, 6500 Bellinzona, Switzerland., Jerak J; Institute for Research in Biomedicine, Università della Svizzera italiana, 6500 Bellinzona, Switzerland., Perotti M; Institute for Research in Biomedicine, Università della Svizzera italiana, 6500 Bellinzona, Switzerland., Jarrossay D; Institute for Research in Biomedicine, Università della Svizzera italiana, 6500 Bellinzona, Switzerland., Jovic S; Institute for Research in Biomedicine, Università della Svizzera italiana, 6500 Bellinzona, Switzerland., Perez L; Institute for Research in Biomedicine, Università della Svizzera italiana, 6500 Bellinzona, Switzerland., Cacciatore R; Laboratory of Immunogenetics, Department of Transfusion Medicine and Immuno-Hematology, Fondazione I.R.C.C.S. Policlinico S. Matteo, 27100 Pavia, Italy., Terrot T; Clinical Trial Unit, Ente Ospedaliero Cantonale, 6500 Bellinzona, Switzerland., Pellanda AF; Clinic of Internal Medicine and Infectious Diseases, Clinica Luganese Moncucco, 6900 Lugano, Switzerland., Biggiogero M; Clinic of Internal Medicine and Infectious Diseases, Clinica Luganese Moncucco, 6900 Lugano, Switzerland., Garzoni C; Clinic of Internal Medicine and Infectious Diseases, Clinica Luganese Moncucco, 6900 Lugano, Switzerland., Ferrari P; Faculty of Biomedical Sciences, Università della Svizzera italiana, 6900 Lugano, Switzerland.; Department of Internal Medicine, Ente Ospedaliero Cantonale, 6500 Bellinzona, Switzerland.; Prince of Wales Hospital Clinical School, University of New South Wales, Sydney, New South Wales 2052, Australia., Ceschi A; Clinical Trial Unit, Ente Ospedaliero Cantonale, 6500 Bellinzona, Switzerland.; Faculty of Biomedical Sciences, Università della Svizzera italiana, 6900 Lugano, Switzerland.; Division of Clinical Pharmacology and Toxicology, Institute of Pharmacological Sciences of Southern Switzerland, Ente Ospedaliero Cantonale, 6900 Lugano, Switzerland.; Department of Clinical Pharmacology and Toxicology, University Hospital Zurich, 8091 Zurich, Switzerland., Lanzavecchia A; National Institute of Molecular Genetics, 20122 Milano, Italy., Sallusto F; Institute for Research in Biomedicine, Università della Svizzera italiana, 6500 Bellinzona, Switzerland. federica.sallusto@irb.usi.ch antonino.cassotta@irb.usi.ch.; Institute of Microbiology, ETH Zürich, 8093 Zurich, Switzerland., Cassotta A; Institute for Research in Biomedicine, Università della Svizzera italiana, 6500 Bellinzona, Switzerland. federica.sallusto@irb.usi.ch antonino.cassotta@irb.usi.ch. |
| Source: | Science (New York, N.Y.) [Science] 2021 Jun 18; Vol. 372 (6548), pp. 1336-1341. Date of Electronic Publication: 2021 May 18. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 0404511 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-9203 (Electronic) Linking ISSN: 00368075 NLM ISO Abbreviation: Science Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
